Adaptation of the sheep pox virus (Poxviridae: Capripoxvirus: Sheeppox virus) to African green monkey kidney cell line and evaluation of its immunobiological properties

Cover Image

Cite item

Full Text

Abstract

Introduction. Outbreaks of infectious diseases seriously hinder the preservation and increase of the number of small ruminants. Such infections include sheep pox virus (SPPV). According to the OIE data of 2021, SPP outbreaks were registered in countries such as Turkey, Israel, China, Maldives, Mongolia, Thailand, Russia, Algeria, Kenya, and in 2019 in Mangistau and Atyrau regions. In Kazakhstan annually conducts routine immunization of sheep at risk with a live attenuated vaccine produced by RIBSP.

Materials and methods. The object of the study was the vaccine strain of NISHI and the virulent strain A of the sheep pox virus. The virus was propagated in Vero cells. To determine the harmlessness and immunogenicity, sheep of the Kazakh fine-wool breed aged from 6 to 12 months were used. Virological, serological and immunobiological methods were used in the study.

Results. The results of the adaptation of the NISHI strain of SPPV to the Vero cell line are presented. Five passages in Vero cells resulted to the adaptation of the NISHI strain with the manifestation of a cytopathogenic effect specific to SPPV with a titer of 6.50 lg TCD50/ml. Following immunization, the formation of immunity was observed in animals on day 7 with an average protective titer 1.8 log2, which increased by day 21 to 4.33 log2.

Conclusion. It has been established that the NISHI strain of SPPV retains its virological and immunobiological properties during reproduction in a Vero cell line.

About the authors

Zhanat T. Amanova

Research Institute for Biological Safety Problems of Ministry of Health of the Republic of Kazakhstan

Email: amanova-janka@mail.ru
ORCID iD: 0000-0002-3987-6814

Master of Sciences (Biological), Senior Researcher, Laboratory of Microorganism Cultivation Technology

Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Zhanna Zh. Sametova

Research Institute for Biological Safety Problems of Ministry of Health of the Republic of Kazakhstan

Email: sametova_zh.zh@mail.ru
ORCID iD: 0000-0002-2332-2841

Master of Sciences (Biotechnological), Researcher, Laboratory of Microorganism Cultivation Technology

Kazakhstan, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

Yerbol A. Bulatov

Research Institute for Biological Safety Problems of Ministry of Health of the Republic of Kazakhstan

Author for correspondence.
Email: erbol_km@mail.ru
ORCID iD: 0000-0001-8543-4219

сandidate of Sciences (Biological), head of the laboratory of Microorganism Cultivation Technology

Russian Federation, 080409, Gvardeyskiy vill., Zhambyl region, Korday district

References

  1. Boumart Z., Daouam S., Belkourati I., Rafi L., Tuppurainen E., Tadlaoui K.O., et al. Comparative innocuity and efficacy of live and inactivated sheeppox vaccines. BMC Vet. Res. 2016; 12(1): 133. https://doi.org/10.1186/s12917-016-0754-0
  2. Yogisharadhya R., Bhanuprakash V., Hosamani M., Venkatesan G., Balamurugan V., Bora D.P., et al. Comparative efficacy of live replicating sheeppox vaccine strains in Ovines. Biologicals. 2011; 39(6): 417–23. https://doi.org/10.1016/j.biologicals.2011.09.010
  3. Yeruham I., Yadin H., Van Ham M., Bumbarov V., Soham A., Perl S. Economic and epidemiological aspects of an outbreak of sheeppox in a dairy sheep flock. Vet. Rec. 2007; 160(7): 236–7. https://doi.org/10.1136/vr.160.7.236
  4. Yune N., Abdela N. Epidemiology and economic importance of sheep and goat pox: a review on past and current aspects. J Vet. Sci. Technol. 2017; 8(2): 430. https://doi.org/10.4262/2157-7579.1000430
  5. Bhanuprakash V., Indrani B.K., Hosamani M., Singh R.K. The current status of sheep pox disease. Comp. Immunol. Microbiol. Infect. Dis. 2006; 29(1): 27–60. https://doi.org/10.1016/j.cimid.2005.12.001
  6. Parilov S.V., Knize A.V., Balyshev V.M. Worldwide distribution analysis & prognosis for sheep & goat pox and peste des petits ruminants in 2011-2015. Politematicheskiy setevoy elektronnyy nauchnyy zhurnal Kubanskogo gosudarstvennogo agrarnogo universiteta. 2011; (69): 423–32. (in Russian)
  7. Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor). The epizootic situation in the world according to the OIE. Available at: https://www.fsvps.ru/fsvps/iac/foreign.htm
  8. OIE. World Organization for Animal Health. Information received on 04/05/2019 from Committee for Veterinary Control and Supervision. Nur-Sultan, Kazakhstan: Ministry of Agriculture; 2019.
  9. Tuppurainen E., Babiuk S., Klement E. Lumpy Skin Disease. Berlin/Heidelberg: Springer International Publishing AG; 2018.
  10. Awad M., Michael A., Soliman S.M., Samir S.S., Daoud A.M. Trials for preparation of inactivated sheep pox vaccine using binary ethyleneimine. Egypt. J. Immunol. 2003; 10(2): 67–72.
  11. Hamdi J., Munyanduki H., Omari Tadlaoui K., El Harrak M., Fassi Fihri O. Capripoxvirus infections in ruminants: a review. Microorganisms. 2021; 9(5): 902. https://doi.org/10.3390/microorganisms9050902
  12. Balyshev V.M., Kalantaenko Yu.F., Gorshkova T.F., Parilov S.V. Combined vaccine against sheep pox and peste des petits ruminants. Patent RF 2406535 S1; 2010. (in Russian)
  13. Barrett P.N., Mundt W., Kistner O., Howard M.K. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev. Vaccines. 2009; 8(5): 607–18. https://doi.org/10.1586/erv.09.19
  14. Trabelsi K., Majoul S., Rourou S., Kallel H. Process intensification for an enhanced replication of a newly adapted RM-65 sheep pox virus strain in Vero cells grown in stirred bioreactor. Biochem. Eng. J. 2014; 90: 131–9. https://doi.org/10.1016/j.bej.2014.06.001
  15. Montagnon B., Vincent-Falquet J.C., Fanget B. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Dev. Biol. Stand. 1984; 55: 37–42.
  16. Trabelsi K., Rourou S., Loukil H., Majoul S., Kallel H. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J. Biotechnol. 2006; 121(2): 261–71. https://doi.org/10.1016/j.jbiotec.2005.07.018
  17. Rourou S., van der Ark A., Majoul S., Trabelsi K., van der Velden T.T., Kallel H. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Appl. Microbiol. Biotechnol. 2009; 85(1): 53–63. https://doi.org/10.1007/s00253-009-2064-y
  18. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine. 2001; 19(31): 4557–65. https://doi.org/10.1016/s0264-410x(01)00208-0
  19. Testerial Manual. Chapter 3.7.12. Sheep Pox and Goat Pox. OIE; 2018: 1513–24.
  20. Amanova Zh.T., Taranov D.S., Ershebulov Z.D., Zhugunisov K.D., Barakbaev K.B., Bulatov E.A., et al. Evaluation of associated vaccine against peste des petits ruminants and sheep pox. Veterinariya. 2016; (9): 21–4. (in Russian)
  21. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938; 27(3): 493–7.
  22. GOST 28085-2013. Biological medicinal products for veterinary use. Methods of sterility control; 2014. (in Russian)
  23. Zaytsev V.L., Sandybaev N.T., Sultankulova K.T., Belousov V.Yu., Chervyakova O.V., Strochkov V.M. Sheep Pox Virus: Molecular Biological Properties and Genome Structure [Virus ospy ovets: molekulyarno-biologicheskie svoystva i struktura genoma]. Almaty; 2011. (in Russian)
  24. Amanova Zh.T., Zhugunisov K.D., Bulatov E.A., Zhunushov A.T., Sametova Zh.Zh., Shayakhmetov E.A., et al. Evaluation of the effectiveness of stabilizing media during lyophilization and storage of the associated vaccine against peste des petits ruminants and sheep pox. Izvestiya Natsional’noy akademii nauk Kyrgyzskoy Respubliki. 2020; (2): 25–34. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Dynamics of accumulation of the NISHI strain in Vero cell culture. *Maximum virus titer. **Minimum virus titer.

Download (46KB)
3. Fig. 2. Cytopathic action of the sheep pox virus on Vero cell culture: a – control culture of Vero cells; b – Vero cell culture infected with sheep pox virus.

Download (199KB)
4. Fig. 3. Dynamics of rectal temperature of sheep immunized with the NISHI strain of the sheep pox virus.*Local reactions that appeared post immunization in 3 sheep were observed for 5 days.

Download (190KB)
5. Fig. 4. Virus neutralizing antibody titers in sheep immunized with the NISHI strain compared to control animals.

Download (59KB)
6. Fig. 5. Dynamics of changes in body temperature of sheep in experimental and control groups after control infection with virulent strain A of the SPP virus. The dotted line in the graph shows the upper limit of the normal body temperature; pp – peak pyrexia in control sheep; 1u – on day 9 post challenge one sheep in the control group was humanely euthanized due to the deterioration of the general condition. *The duration of local reactions that occurred after infection in sheep from the experimental and control groups.

Download (154KB)

Copyright (c) 2022 Amanova Z.T., Sametova Z.Z., Bulatov Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies